罗哌卡因复合舒芬太尼连续硬膜外麻醉在初产妇分娩镇痛中的应用效果观察

Effect of Continuous Epidural Anesthesia Combined with Ropivacaine and Sufentanil on Labor Analgesia in Primipara

目的探讨罗哌卡因复合舒芬太尼连续硬膜外麻醉在初产妇分娩镇痛中的应用效果。方法选取2020年8月—2023年8月镇宁布依族苗族自治县人民医院收治的70例分娩初产妇为研究对象,按随机数字表法将其分为对照组和观察组,各35例。对照组行常规分娩,观察组行连续硬膜外麻醉分娩。比较两组镇痛效果、产程时间、分娩方式及不良妊娠结局发生情况。结果观察组镇痛总有效率为91.43%,高于对照组的2.86%,差异有统计学意义(P<0.05)。观察组第一产程时间短于对照组,差异有统计学意义(P<0.05)。观察组自然分娩率高于对照组,差异有统计学意义(P<0.05)。观察组不良妊娠结局发生率低于对照组,差异有统计学意义(P<0.05)。结论持续硬膜外麻醉在初产妇分娩镇痛中的应用,可有效地起到镇痛效果,缩短分娩产程,改善妊娠结局,值得临床提倡和推广。

Objective To explore the effect of continuous epidural anesthesia combined with ropivacaine and sufentanil on labor analgesia in primipara.Methods Seventy cases of parturient parturients in Zhening Buyi and Miao Autonomous County People's Hospital from August 2020 to August 2023 were selected as the research objects,and were divided into control group and observation group according to random number table method,with 35 cases in each group.The control group received routine delivery,the observation group received continuous epidural anesthesia delivery.The analgesic effect,labor time,delivery mode and the occurrence of adverse pregnancy outcome were compared between the two groups.Results The effective rate of analgesia in observation group was 91.43%,which was higher than 2.86%in control group,the difference was statistically significant(P<0.05).The first stage of labor in the observation group was shorter than that in the control group,and the difference was statistically significant(P<0.05).The rate of natural childbirth in the observation group was higher than that in the control group,and the difference was statistically significant(P<0.05).The incidence of adverse pregnancy outcome in observation group was lower than that in control group,and the difference was statistically significant(P<0.05).Conclusion The application of continuous epidural anesthesia in parturient labor analgesia can effectively play an analgesic effect,shorten the labor process and improve the pregnancy outcome,which is worthy of clinical advocacy and promotion.